| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 07/21/2011 | US20110177114 Immediate protection against pathogens via mva |
| 07/21/2011 | US20110177112 Multi- component l2 vaccine for prevention of human papilloma virus infection |
| 07/21/2011 | US20110177111 Protective vaccine against staphylococcus aureus biofilms comprising cell wall-associated immunogens |
| 07/21/2011 | US20110177110 Compositions comprising cationic microparticles and hcv e1e2 dna and methods of use thereof |
| 07/21/2011 | US20110177107 Predicting and reducing alloimmunogenicity of protein therapeutics |
| 07/21/2011 | US20110177106 Novel Therapeutic Methods for Treating Inflammation and Immune System Disorders |
| 07/21/2011 | US20110177105 Novel Selective Inhibitors of Ubiquitin Specific Protease 7, the Pharmaceutical Compositions Thereof and Their Therapeutic Applications |
| 07/21/2011 | US20110177104 Method for selective depletion of cd137 positive cells using anti-cd137 antibody-toxin complex |
| 07/21/2011 | US20110177093 Use of bcma as an immunoregulatory agent |
| 07/21/2011 | US20110177090 Glycan markers and autoantibody signatures in HIV-1 and HIV-1-associated malignancies |
| 07/21/2011 | US20110177071 Immunosuppressive polypeptides and nucleic acids |
| 07/21/2011 | US20110177066 Prevention and treatment of amyloidogenic diseases |
| 07/21/2011 | US20110177065 Methods of treating/preventing inflammation using combination of il-1 antagonist and il-18 binding protein |
| 07/21/2011 | US20110177044 Nutritional Formulas Containing Synbiotics |
| 07/21/2011 | US20110177040 Cytokine Induction Of Selectin Ligands On Cells |
| 07/21/2011 | US20110177024 Use of truncated cysteine il28 and il29 mutants to treat cancers and autoimmune disorders |
| 07/21/2011 | US20110177023 Genetically modified human umbilical cord perivascular cells for prophylaxis against or treatment of biological or chemical agents |
| 07/21/2011 | US20110177011 Certain imidazo[1,2-a]pyrazin-8-ylamines and method of inhibition of bruton's tyrosine kinase by such compounds |
| 07/21/2011 | CA2786800A1 Thiazole and oxazole kinase inhibitors |
| 07/21/2011 | CA2785499A1 Isoindolinone inhibitors of phosphatidylinositol 3-kinase |
| 07/21/2011 | CA2782757A1 Stem cell immune modulation methods of use and apparatus |
| 07/21/2011 | CA2781578A1 Tricyclic heterocyclic compounds, compositions and methods of use thereof |
| 07/20/2011 | EP2345720A2 In vivo production of small interfering RNAs that mediate gene silencing |
| 07/20/2011 | EP2345670A1 Use of soluble forms of CD83 and nucleic acids encoding them for the treatment or prevention of diseases |
| 07/20/2011 | EP2345424A1 CD4-specific antibody TRX1 and uses therefor |
| 07/20/2011 | EP2345418A1 Milk fat for the treatment of mucositis |
| 07/20/2011 | EP2345412A1 Use of high-dose oxazaphosphorine drugs for treating immune disorders |
| 07/20/2011 | EP2345405A1 Substance for restoring normal co-expression and interaction between LOX and NRAGE proteins |
| 07/20/2011 | EP2344538A2 Antibodies against il-25 |
| 07/20/2011 | EP2344522A1 Combination adjuvant formulation |
| 07/20/2011 | EP2344514A2 Synthetic methods and derivatives of triphosphate oligonucleotides |
| 07/20/2011 | EP2344490A2 4-morpholino-pyrido[3,2-d]pyrimidines active on pi3k |
| 07/20/2011 | EP2344486A2 Alkylthiazol carbamate derivatives, preparation thereof and therapeutic use thereof |
| 07/20/2011 | EP2344465A1 Crystalline forms of (r) -5- [3-chloro-4-( 2, 3-dihydroxy-propoxy)-benz [z]ylidene]-2- [z]-propylimino) -3-0-tolyl-thiazolidin-4-one |
| 07/20/2011 | EP2344463A2 1,2 -thiazol yl derivatives as cannabinoid receptor ligands |
| 07/20/2011 | EP2344189A2 Protective vaccine against staphylococcus aureus biofilms comprising cell wall-associated immunogens |
| 07/20/2011 | EP2344184A2 Methods for inducing a sustained immune response againts a b-cell idiotype using autologous anti-idiotypic vaccines |
| 07/20/2011 | EP2344183A1 Dosage forms that facilitate rapid activation of zymogen |
| 07/20/2011 | EP2344152A2 Oral vaccines for producing mucosal immunity |
| 07/20/2011 | EP2344150A2 Nutritional support to prevent and/or mitigate bone marrow toxicity from a cancerous tumor |
| 07/20/2011 | EP2344148A2 Nutritional support to prevent or moderate bone marrow paralysis or neutropenia during anti-cancer treatment |
| 07/20/2011 | EP2344147A2 Nutritional support of the immune system during anti-cancer treatment |
| 07/20/2011 | EP2168581A9 Stable polymorph of N-(3-ethynylphenylamino)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine hydrochloride, methods of production, and pharmaceutical uses thereof |
| 07/20/2011 | EP2125788B9 Heterocyclic compounds, compositions comprising them and methods of their use |
| 07/20/2011 | EP2111228B1 10Fn3 domain for use in treating diseases associated with inappropriate angiogenesis |
| 07/20/2011 | EP1218007B1 Optically active isomers of ketotifen and therapeutically active metabolites thereof |
| 07/20/2011 | EP1157043B1 Anti-gpr-9-6 and anti-teck antibodies and methods of identifying modulators of gpr-9-6 and teck functions |
| 07/20/2011 | CN201899709U Astragalus polyose micropill |
| 07/20/2011 | CN1993469B Recombinant alpha-fetoprotein, method and means for preparation thereof, compositions on the base thereof and use thereof |
| 07/20/2011 | CN1985875B Preparing process of Jade-screen total polyose |
| 07/20/2011 | CN1950360B Substituted pyrrole-2, 5-diones as protein kinase c inhibitors |
| 07/20/2011 | CN1781933B Thymosin alpha 1 active segment cyclicpeptide analogue and its poly glycol derivative |
| 07/20/2011 | CN102131830A Chimeric respiratory syncytial virus polypeptide antigens |
| 07/20/2011 | CN102131812A Pyrrolo[2,3-d]pyrimidine compounds |
| 07/20/2011 | CN102131809A Tri-cyclic pyrazolopyridine kinase inhibitors |
| 07/20/2011 | CN102131808A Pyrazolopyridine kinase inhibitors |
| 07/20/2011 | CN102131807A Pyrazolopyridine kinase inhibitors |
| 07/20/2011 | CN102131803A Solid forms of (1r,2s,3r)-1-(2-(isoxazol-3-yl)-1h-imidazol-4-yl)butane-1,2,3,4-tetraol and methods of their use |
| 07/20/2011 | CN102131788A Compounds and compositions as protein kinase inhibitors |
| 07/20/2011 | CN102131784A Substituted isoquinolines and isoquinolinones as rho kinase inhibitors |
| 07/20/2011 | CN102131523A Modified beta-lactoglobulins for immunotherapy of milk allergy |
| 07/20/2011 | CN102131522A HIV combination vaccine and prime boost method |
| 07/20/2011 | CN102131504A Combinations comprising bicyclic S1P lyase inhibitors |
| 07/20/2011 | CN102131502A Nutritional composition for improving mammalian immune system |
| 07/20/2011 | CN102127160A Scorpion active polypeptides as well as preparation method and application thereof |
| 07/20/2011 | CN102127078A Heterocyclic janus kinase 3 inhibitors |
| 07/20/2011 | CN102127071A Pyridine cyclo-derivative |
| 07/20/2011 | CN102127057A Dipeptidyl peptidase inhibitors |
| 07/20/2011 | CN102127056A Tubulin inhibitors |
| 07/20/2011 | CN102127054A 3-(substituted dihydroisoindol-2-yl)-2,6-piperidinedione polymorph and pharmaceutical composite |
| 07/20/2011 | CN102127053A Dipeptidyl peptidase inhibitors |
| 07/20/2011 | CN102125692A Wrapping agent in levo-carnitine wrapping technology and composition of ten series products and preparation method |
| 07/20/2011 | CN102125637A Externally applied Chinese medicine bag |
| 07/20/2011 | CN102125560A Uses of DPP-IV inhibitors |
| 07/20/2011 | CN102125537A Novel medical application of resveratrol and derivatives thereof |
| 07/20/2011 | CN102125147A Health care tea |
| 07/20/2011 | CN101843705B Chinese medicament for treating lupus erythematosus |
| 07/20/2011 | CN101837032B Blueberry anthocyanin oral solution |
| 07/20/2011 | CN101829075B Applications of kukoamine A and kukoamine B |
| 07/20/2011 | CN101816668B Medical application of 2-O-alpha-L-rhamnose-4,6,4'-trihydroxybenzophenone |
| 07/20/2011 | CN101664434B Composite traditional Chinese medicine composition and preparation method and application thereof |
| 07/20/2011 | CN101664422B Supercritical fluid extract technology of ganoderma volatile oil, ganodenic acid and ganoderma polysaccharide |
| 07/20/2011 | CN101637484B Active extract for sanwei sandalwood as well as extraction method and medical application thereof |
| 07/20/2011 | CN101619089B Anticancer drug CL168, synthesis method and application thereof |
| 07/20/2011 | CN101538545B Lactobacillus salivarius and food composition thereof |
| 07/20/2011 | CN101537082B Health wine capable of enhancing immunity and reliving physical fatigue and production method and applications thereof |
| 07/20/2011 | CN101530429B New use of clarias lazera |
| 07/20/2011 | CN101502607B Cordyceps sinensis and mushroom composition, Cordyceps sinensis and mushroom polysaccharide oral liquid, and preparation method thereof |
| 07/20/2011 | CN101439119B External-use medicament for treating urticaria, eczema and skin pruritus |
| 07/20/2011 | CN101343606B Life prolonging wine and preparation |
| 07/20/2011 | CN101297669B Chitosan oral scented pieces and preparation thereof |
| 07/20/2011 | CN101214307B Chinese medicine powder medicine for treating eczema especially ear eczema |
| 07/20/2011 | CN101148410B Method for extracting high pure chicoric acid from Coneflower |
| 07/20/2011 | CN101073595B Glycyrrhiza total flavonoid and total saponin extract and its production |
| 07/20/2011 | CN101023987B Method for preparing medicine for treating allergic rhinitis |
| 07/19/2011 | US7982067 Phenethanolamine derivatives for treatment of respiratory diseases |
| 07/19/2011 | US7982037 (5-Methyl-2H-pyrazol-3-yl)-(2-phenylsulfanyl-quinazolin-4-yl)-amine; Anticancer agents; antidiabetic agents; Alzheimer's disease; inhibitors of Aurora-2 and GSK-3 |
| 07/19/2011 | US7981900 2-phenyl pyrimidines which are tubulin inhibitors |
| 07/19/2011 | US7981865 Antigenic fragments of human factor VIII polypeptides |
| 07/19/2011 | US7981660 Methods for producing modified glycoproteins |